This study is looking at the genes involved in lung diseases like cystic fibrosis, pulmonary fibrosis, tuberous sclerosis, asthma, and pulmonary sarcoidosis. Researchers want to understand how genetic factors contribute to the development of these conditions. They will examine genes in lung cells from people with lung disease and healthy volunteers. The main goal is to see how hereditary factors play a role in lung disease over one year. You might be able to join if you are between 2 and 90 years old and have a lung condition, especially if you have alpha-1 antitrypsin (AAT) deficiency, or symptoms and X-ray findings consistent with lung disease.

Study design

This is an observational study with a planned enrollment of 3500 participants. It is designed to evaluate genetic mechanisms of lung disease.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint evaluates the role of hereditary factors at 1 year.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.